Product Information
APTENSIO XR 15 MG CAPSULE is a brand product labeled by Rhodes Pharmaceuticals L.P., priced at $7.9647 per EA under NDC 42858040245. Its NADAC has been published 158 times since Feb 19, 2020.
Strength
15 mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858040245
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
METHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205831On Market Since
4/17/2015
Pharmacological Classes
Price Statistics
The NADAC for APTENSIO XR 15 MG CAPSULE has been published 158 times since Feb 19, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.9647 per EA |
|---|---|
| All-time high | $8.0184 (Dec 11, 2024) |
| All-time low | $7.9500 (Feb 19, 2025) |
| 52-week high | $7.9647 |
| 52-week low | $7.9647 |
| Median price | $7.9893 |
| Average price | $7.9858 |
| Largest weekly change | -0.5% (Feb 19, 2025) |
| Weeks tracked | 158 |
| Tracking since | Feb 19, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of APTENSIO XR 15 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for APTENSIO XR 15 MG CAPSULE, manufactured by Rhodes Pharmaceuticals L.P., is $7.9647 per EA (NDC 42858040245), effective Jun 24, 2026.
How has the price of APTENSIO XR 15 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for APTENSIO XR 15 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 158 weekly CMS publications since Feb 19, 2020.
What are the highest and lowest recorded NADAC prices for APTENSIO XR 15 MG CAPSULE?
Since Feb 19, 2020, the NADAC for APTENSIO XR 15 MG CAPSULE has ranged from a low of $7.9500 (Feb 19, 2025) to a high of $8.0184 (Dec 11, 2024), with a median of $7.9893 per EA.
Are there cheaper alternatives to APTENSIO XR 15 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE ER 15 MG CAP, is $2.6482 per EA — about 67% below APTENSIO XR 15 MG CAPSULE.
Who manufactures APTENSIO XR 15 MG CAPSULE?
APTENSIO XR 15 MG CAPSULE (NDC 42858040245) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a brand product.
Related Drugs
Same classification